MicroRNAs (miRNAs) are endogenous, short (~22 nucleotide), evolutionarily conserved, non-coding RNAs that regulate gene expression at the post-transcriptional level. Recent evidence suggests that miRNAs are differentially expressed in the failing myocardium and play an important role in progression of heart failure by targeting genes that govern diverse functions in cardiac remodeling process including myocyte hypertrophy, excitation-contraction coupling, increased myocyte loss, and myocardial fibrosis. In addition to their role in adverse cardiac remodeling, miRNAs hold promise as biomarkers of disease progression in heart failure given their presence in circulation and enhanced stability. Further development of miR-based therapeutics may allow for modulation of cardiac and/or systemic levels of specific miRNAs in patients with heart failure . Here, we summarize current knowledge of miRNAs in relation to their role in regulating various aspects of the cardiac remodeling process and discuss their potential use as biomarkers and/or therapeutic targets in heart failure.

Original languageEnglish
Pages (from-to)171-182
Number of pages12
JournalCardiovascular Drugs and Therapy
Issue number2
StatePublished - Apr 2011


  • Cardiac remodeling
  • Gene silencing
  • Personalized medicine
  • microRNAs


Dive into the research topics of 'Role of microRNAs in cardiac remodeling and heart failure'. Together they form a unique fingerprint.

Cite this